| NCT ID | NCT04253379 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CHU de Reims |
| Condition | Pediatric Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2020-02-02 |
| Primary Completion | 2026-10-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2020-02-02 with a primary completion date of 2026-10-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the development of social cognition skills in pediatric epilepsy compared to healthy children. There are evidences indicating that children with epilepsy have executive dysfunctions and language problems. Executive functions refer to multiple cognitive processes that contribute to human higher order abilities, such as purposeful and future-orientated behavior. Moreover, the literature regarding development of non epileptic children, with ordinary development indicates that executive functions and language are linked to the emergence of social cognition. Then, the investigators asked if children with epilepsy, as they commonly present executive dysfunctions, would show an atypical development of social cognition. Children with epilepsy and a control group of healthy volunteers will be compared to identify relationships between executive functions, language and social cognition.
Eligibility Criteria
Inclusion Criteria: * exposed children : children aged 6-12 with a diagnosis of epilepsy French native speaker * A control group of age-matched children who meet patient selection criteria with the exception of the epilepsy will also be sought Exclusion Criteria: * neurological or psychiatric disease in control group * Raven's Matrices score \< percentile 10
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04253379 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Pediatric Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04253379 currently recruiting?
Yes, NCT04253379 is actively recruiting participants. Contact the research team at mjennesson-lyver@chu-reims.fr for enrollment information.
Where is the NCT04253379 trial being conducted?
This trial is being conducted at Reims, France.
Who is sponsoring the NCT04253379 clinical trial?
NCT04253379 is sponsored by CHU de Reims. The trial plans to enroll 96 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.